MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
252 hedge funds and large institutions have $4.7B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 97 increasing their positions, 71 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
44% less capital invested
Capital invested by funds: $8.33B → $4.7B (-$3.63B)
Holders
252
Holding in Top 10
9
Calls
$56.9M
Puts
$31.6M
Top Buyers
| 1 | +$51.4M | |
| 2 | +$48.2M | |
| 3 | +$43.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$41.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$31.9M |
Top Sellers
| 1 | -$74.3M | |
| 2 | -$70.4M | |
| 3 | -$54.6M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$46.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$43.6M |